Alembic Pharmaceuticals has raised ₹3500 million through allotment of non-convertible debentures (NCDs) on private placement basis. The NCD committee of Alembic Pharmaceuticals Ltd has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs) aggregating to ₹1500 million under tranche I.
The company has also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs aggregating to ₹2000 million.
Company Profile : Alembic Pharmaceuticals Ltd
Leave a Reply